// App-Quantinova.ai

268 : PARP3 inhibitors in cancer therapy

Researchers

Presenter

  • Bahram Sharif-Askari

Principal Investigators

  • David Davidson

  • Lilian Amrein

  • Lawrence Panasci

Medical Centers

  • Faculty of Medicine, Department of Oncology, McGill University, Segal Cancer Center, Lady Davis Institute, Montreal, Quebec, Canada.

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Poly(ADP-Ribose) Polymerase 1

  • Protein Kinase, DNA-Activated, Catalytic Subunit

  • Ku70

  • X-Ray Repair Cross Complementing 5

Drug/Treatment

  • ribose

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved